Can norepinephrine (noradrenaline) be diluted in normal saline (0.9% sodium chloride) or 5% dextrose in water (D5W) for infusion, and should plain normal saline be avoided for prolonged infusion times?

Norepinephrine Dilution: Both Normal Saline and Dextrose Are Acceptable, But Dextrose Is Preferred for Stability

Norepinephrine can be safely diluted in either normal saline (NS) or 5% dextrose in water (D5W), but D5W is the preferred diluent for prolonged infusions due to superior drug stability and reduced risk of oxidation. 1

Diluent Selection Based on FDA Labeling and Guidelines

The FDA-approved labeling for norepinephrine explicitly states that "LEVOPHED should be diluted in 5 percent dextrose injection or 5 percent dextrose and sodium chloride injections. These dextrose containing fluids are protection against significant loss of potency due to oxidation. Administration in saline solution alone is not recommended." 1 This represents the highest level of evidence as official drug labeling.

However, clinical practice has evolved beyond this original recommendation:

For Prolonged Infusions (>24 hours):

• Use D5W as the default diluent 1
• Dextrose-containing solutions protect against oxidative degradation of norepinephrine
• Research confirms norepinephrine remains chemically stable for 7 days in D5W at room temperature 2

For Short-Duration Peripheral Infusions:

• Normal saline is acceptable and may be preferred 3, 4
• Recent systematic review supports 0.9% saline as the default diluent for peripheral norepinephrine administration 3
• This recommendation emerged from a critical incident where dilute norepinephrine (4 μg/mL) in D5W caused severe hyponatremia and seizure 4

Critical Safety Considerations

The Hyponatremia Risk with D5W

A case report documented a patient who developed severe hyponatremia (sodium 115 mmol/L) and seizure after receiving highly diluted norepinephrine (4 μg/mL) in D5W through a peripheral line 4. The large volume of free water from D5W, combined with the dilute concentration, created a dangerous electrolyte imbalance. Following this incident, institutional protocols changed to recommend normal saline as the default diluent for peripheral norepinephrine.

The Hypernatremia Risk with NS

Conversely, using NS to dilute drugs and maintain catheter patency is a major modifiable risk factor for ICU-acquired hypernatremia 5. Patients receiving multiple drugs diluted in NS can accumulate dangerous sodium loads, particularly when combined with positive fluid balances.

Practical Algorithm for Diluent Selection

For Central Line Administration:

• Standard concentration (16-32 μg/mL): Use D5W 1
• Duration >24 hours: Use D5W 2
• Monitor sodium levels regardless of diluent choice

For Peripheral Line Administration:

• Use NS as default diluent 3, 4
• Keep concentration ≥16 μg/mL to minimize volume 4
• Maximum duration: 24 hours 6
• Strict monitoring protocols mandatory 6

Special Circumstances:

• If patient has hypernatremia: Use D5W but monitor sodium closely
• If patient has hyponatremia: Use NS exclusively
• If using dilute concentrations (<16 μg/mL): NS is mandatory to prevent free water overload 4

Concentration and Stability Data

Research demonstrates that norepinephrine solutions at both 4 μg/mL and 16 μg/mL concentrations remain chemically stable for 7 days at room temperature under ambient light when diluted in either D5W or NS 2. The concentration ratios at 168 hours compared to baseline were 95.7% (D5W) and 96.4% (NS) for the 4 μg/mL concentration, and 104.5% (D5W) and 96.4% (NS) for the 16 μg/mL concentration.

Peripheral Administration Guidelines

Recent guidelines from the Association of Anaesthetists state that "potent peripheral vasoconstrictors such as noradrenaline may be infused for short durations through appropriately positioned short peripheral catheters and at dilute concentrations. Strict protocols should be followed." 6

Key requirements for peripheral norepinephrine:

• Use appropriately sized peripheral catheter (18-20 gauge preferred)
• Position in large, proximal veins (antecubital fossa)
• Dilute concentrations to reduce extravasation injury risk
• Maximum duration 24 hours
• Continuous monitoring for signs of extravasation
• Have phentolamine immediately available for extravasation treatment 3

Common Pitfalls to Avoid

1. Never use highly dilute norepinephrine (<16 μg/mL) in D5W for peripheral infusions - this combination creates unacceptable hyponatremia risk 4

2. Don't assume NS is always safer - prolonged use contributes to hypernatremia, particularly when used for multiple drug dilutions 5

3. Avoid using NS alone for central line infusions lasting >24 hours - oxidative degradation may reduce potency despite research showing stability 1

4. Don't prepare norepinephrine solutions without proper mixing - inadequate mixing creates dangerous concentration inhomogeneities with variability up to 39% 7. Use the "Bubble-Flip" method: aspirate 5 mL of air into the syringe, then invert to ensure homogeneous mixing.